The specific mechanism of HOXB13 controlling the IGF-1R expression warrants further analysis, although it is suggested that the FTO/HOXB13/IGF-1R/PI3K/Akt/mTOR axis should be explored as a potential therapeutic target for GC (104). The gene discussed is IGF1R; the disease is gastric cancer.